The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Employment - Merck
Stock and Other Ownership Interests - Merck
Employment - Merck
Stock and Other Ownership Interests - Merck

Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase 3 KEYNOTE-181 study.
Manish A. Shah
Consulting or Advisory Role - Astellas Pharma
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); Merck (Inst); Oncolys BioPharma (Inst)
Antoine Adenis
Honoraria - Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Sanofi; SERVIER
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Novartis; Sanofi
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Merck; Merck Serono; Sanofi
Peter C. Enzinger
Consulting or Advisory Role - Astellas Pharma; Five Prime Therapeutics; Merck; Taiho Pharmaceutical
Takashi Kojima
Honoraria - Oncolys BioPharma
Research Funding - Astellas Amgen BioPharama (Inst); MSD (Inst); Oncolys BioPharma (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
Kei Muro
Honoraria - Bayer; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Gilead Sciences (Inst); Kyowa Hakko Kirin (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst)
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
Honoraria - Amgen; Bayer; Lilly; Novartis; Sanofi
Consulting or Advisory Role - Merck Serono; Roche; SERVIER
Travel, Accommodations, Expenses - Roche; SERVIER
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Ono Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
Toshikazu Moriwaki
Research Funding - Boehringer Ingelheim; MSD; Taiho Pharmaceutical; Takeda; Yakult Honsha
Sung-Bae Kim
Consulting or Advisory Role - Enzychem Lifesciences (Inst); Lilly (Inst); Novartis (Inst); Odonate Therapeutics (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
Se-Hoon Lee
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis
Research Funding - Merck
Travel, Accommodations, Expenses - Novartis
Ken Kato
Consulting or Advisory Role - BeiGene; MSD; Oncolys BioPharma; Oncolys BioPharma; Ono Pharmaceutical
Research Funding - Beigene (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
Lin Shen
Consulting or Advisory Role - Jiangsu Hengrui Medicine
Research Funding - Jiangsu Hengrui Medicine
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine
Shukui Qin
No Relationships to Disclose
Paula Ferreira
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - MSD; Novartis
Ruixue Wang
Employment - Merck
Stock and Other Ownership Interests - Merck
Pooja Bhagia
No Relationships to Disclose
S. Peter Kang
No Relationships to Disclose
Jean-Philippe Metges
Honoraria - Bayer Health; Lilly
Consulting or Advisory Role - Erytech Pharma; Sanofi
Research Funding - Bristol-Myers Squibb; Merck
Toshihiko Doi
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Daiichi Sankyo; Kyowa Hakko Kirin; MSD; Novartis; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst)